Lexicon and Novo Nordisk: first clinical phase for an innovative obesity drug
Deepdives·LXRX·Mar 24, 2026·2 min read
Deepdives
LXRX
Lexicon and Novo Nordisk: first clinical phase for an innovative obesity drug
Mar 24, 2026 · 2 min
Stocks far from their peak: has the train left the station?
On Our Radar·CELH·Apr 28, 2025·2 min read
On Our Radar
CELH
Stocks far from their peak: has the train left the station?
Apr 28, 2025 · 2 min